Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
Phase 3
- Conditions
- Follicular Lymphoma
- Interventions
- Drug: R-CVPDrug: R-CHOPDrug: R-FM
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2011-02-15
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 534
- Registration Number
- NCT00774826
- Locations
- 🇮🇹
Osp. San Carlo Borromeo Divisione di Oncologia Medica, Milano, Italy
🇮🇹Ospedale Niguarda CA' Granda, Milano, Italy
🇮🇹AORN Cardarelli U.O.Ematologia, Napoli, Italy
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Phase 3
- Conditions
- Diffuse Large B-Cell LymphomaIPI≥2
- Interventions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2011-02-15
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 399
- Registration Number
- NCT00499018
- Locations
- 🇮🇹
Istituto Vito Fazzi, Lecce, Italy
🇮🇹Ospedale Umberto I - DH Oncoematologico, Nocera Inferiore, Salerno, Italy
🇮🇹Az. Osp. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
© Copyright 2025. All Rights Reserved by MedPath